Cycloset available for type 2 diabetes - ONA

Links shared publicly online about this topic.

  • 723
    total visits

Cycloset available for type 2 diabetes - ONA

oncologynurseadvisor.com

Santarus announced that Cycloset (bromocriptine mesylate tablets), a dopamine receptor agonist, has been made available for the management of type 2 diabetes as an adjunct to diet and exercise.

View full resource at oncologynurseadvisor.com

Tags: Diabetes, Type 2 Diabetes, Parkinson's Disease Medication, Diet and Nutrition, Exercise and Fitness, Parlodel

  • Share

Most Recently Shared on November 16, 2010 at 2:59 pm By:

ACP Pressroom - American College of Physicians and Consumer Reports Announce Collaboration on New High Value Care Patient Education Resources

acponline.org — “ACP Pressroom - American College of Physicians and Consumer Reports Announce Collaboration on New High Value Care Patient Education ResourcesView full resource at acponline.org

  • View Related
  • Share

Most Recently Shared on April 19, 2012 at 7:34 pm By:

ACPinternists ACP Medical Society

ACP & Consumer Reports collaborate http://t.co/QKME3Ltn to help patients understand appropriate treatments for common clinical issues

4 weeks ago...

Free diabetes risk test available Tuesday | News-Gazette.com

news-gazette.com — “CHAMPAIGN — Type 2 diabetes often goes undetected in its early stages, but next week everyone will get a chance to assess their risk for this serious disease by taking a quick, free test.View full resource at news-gazette.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 6:20 pm By:

Diabetes_Type2 Diabetes, Type 2 OW Health

Free diabetes risk test available Tuesday: CHAMPAIGN — Type 2 diabetes often goes undetected in its early stages... http://t.co/kRzLfroU

2 months ago...

ACP Guideline on Type 2 Diabetes Recommends Oral Pharmacology as Second-line Therapy -- AAFP News Now -- American Academy of Family Physicians

aafp.org — “The American College of Physicians has issued a guideline that provides three clinical recommendations regarding the comparative effectiveness and safety of type 2 diabetes medications. The guideline specifically addresses the pharmacologic management of patients with type 2 diabetes using agents from any of 11 unique classes of drugs available to treat hyperglycemia in these patients.View full resource at aafp.org

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 6:37 pm By:

aafp AAFP Medical Society

ACP Guideline on Type 2 Diabetes Recommends Oral Pharmacology as Second-line Therapy http://t.co/PBkWUXwH

2 months ago...

ACP Guideline on Type 2 Diabetes Recommends Oral Pharmacology as Second-line Therapy -- AAFP News Now -- American Academy of Family Physicians

aafp.org — “The American College of Physicians has issued a guideline that provides three clinical recommendations regarding the comparative effectiveness and safety of type 2 diabetes medications. The guideline specifically addresses the pharmacologic management of patients with type 2 diabetes using agents from any of 11 unique classes of drugs available to treat hyperglycemia in these patients.View full resource at aafp.org

  • View Related
  • Share

Most Recently Shared on March 23, 2012 at 6:17 pm By:

Diabetes_Type2 Diabetes, Type 2 OW Health

ACP Guideline on Type 2 Diabetes Recommends Oral Pharmacology as Second-line Therapy: The American College of Ph... http://t.co/eccl3Dmt

2 months ago...

Access to Health Care - American Diabetes Association

diabetes.org — “We are committed to expanding the number of people with diabetes who have insurance, and to ensuring that coverage is adequate, affordable and available.View full resource at diabetes.org

  • View Related
  • Share

Most Recently Shared on March 19, 2012 at 1:18 pm By:

AmDiabetesAssn Amer. Diabetes Assn. Health Organization

The Affordable Care Act est. the Nat’l #Diabetes Prevention Program to prevent onset of #type2 in ppl w/prediabetes: http://t.co/W0ZqHfyB

2 months ago...

White Rice Postulated to Increase Diabetes Risk - Physician's First Watch

firstwatch.jwatch.org — “A meta-analysis finds increased risk for type 2 diabetes with high consumption of white rice. A comment in BMJ cautions against major dietary changes, however. (A brief interview with the senior author is available through . . . LINK(S):View full resource at firstwatch.jwatch.org

  • View Related
  • Share

Most Recently Shared on March 17, 2012 at 8:48 am By:

Boehringer Ingelheim and Lilly's new oral type 2 diabetes treatment... -- RIDGEFIELD, Conn. and INDIANAPOLIS, March 7, 2012 /PRNewswire/ --

prnewswire.com — “Boehringer Ingelheim and Lilly's new oral type 2 diabetes treatment for adults, Jentadueto™ (linagliptin/metformin hydrochloride) tablets, now available in U.S. pharmacies. JENTADUETO, available in three dosage strengths, further expands treatment options for people living with diabetes.View full resource at prnewswire.com

  • View Related
  • Share

Most Recently Shared on March 7, 2012 at 5:13 pm By:

sstrumello Scott Strumello Patient Expert

Boehringer Ingelheim & Lilly's new oral type 2 diabetes treatmt, Jentadueto™, now avail in US pharmacies http://t.co/gYbPMVrL via PRNewswire

2 months ago...

Diabetes Risk Test - American Diabetes Association

diabetes.org — “Diabetes Risk TestView full resource at diabetes.org

  • View Related
  • Share

Most Recently Shared on February 24, 2012 at 3:14 pm By:

AmDiabetesAssn Amer. Diabetes Assn. Health Organization

@Tellab77 @AmDiabetesEOK Sure! Our #Diabetes Risk Test is available year-round & we'll have a new, improved one 3/27! http://t.co/jJC0vEya

3 months ago...

Bydureon Available for Type 2 Diabetes - MPR

empr.com — “Bydureon (Amylin and Alkermes), a once-weekly formulation of exenatide, has been made available for the treatment of type 2 diabetes.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on February 13, 2012 at 7:29 pm By:

FDA Gives Long-Awaited Nod to Amylin’s Bydureon - Diabetes Health

diabeteshealth.com — “Diabetes Health - Medications: Bydureon. After several years of delays and setbacks, Amylin Pharmaceuticals has received FDA approval to begin US marketing of BydureonTM. The first once-a-week type 2 therapy to be offered in the US market, Bydureon is expected to be available by February.View full resource at diabeteshealth.com

  • View Related
  • Share

Most Recently Shared on February 3, 2012 at 1:01 pm By:

DiabetesHealth Diabetes Health Health Site

FDA Gives Long-Awaited Nod to Amylin's Bydureon http://t.co/jW3wcqE4

3 months ago...

liraglutide exenatide - TuDiabetes

tudiabetes.org — “Is anyone taking or has taken liraglutide exenatide? It's a Type 2 steroid drug similar to symlin (which is not available in Canada where I live). I've been ta…View full resource at tudiabetes.org

  • View Related
  • Share

Most Recently Shared on November 26, 2011 at 3:27 am By:

tudiabetes a diabetes community Support

Type1 diabetes: liraglutide exenatide - Is anyone taking or has taken liraglutide exenatide? It's a Type 2 steroid d... http://t.co/oRakOUbb

6 months ago...

The Pros & Cons of Insulin Therapy | Healthline

healthline.com — “Learn the benefits and pitfalls of insulin therapy, including using needles, checking blood sugar level, diet management, and more. Read on!View full resource at healthline.com

  • View Related
  • Share

Most Recently Shared on November 22, 2011 at 6:40 pm By:

DiabetesLine Healthline Diabetes Health Site

Pros & Cons of Insulin Therapy: Decide with your doctor how your treatment can be best managed to fit your lifestyle. http://t.co/M8vJ3dKN

6 months ago...

Juvisync Available for Type 2 Diabetes and High Cholesterol - MPR

empr.com — “Merck announced that Juvisync, a fixed-dose combination product containing the dipeptidyl peptidase 4 (DPP-4) inhibitor sitagliptin and the HMG-CoA reductase inhibitor simvastatin is now available.View full resource at empr.com

  • View Related
  • Share

Most Recently Shared on October 26, 2011 at 1:57 pm By:

FDA OKs diabetes, cholesterol combo drug - Related Stories - DiabetesPro SmartBrief

smartbrief.com — “Merck & Co. secured marketing approval from the FDA for Juvisync, a treatment containing the firm's type 2 diabetes pill Januvia and cholesterol-lowering statin simvastatin. The combination was approved for marketing in multiple strengths. "Dose selection should factor in what other drugs the patie…View full resource at smartbrief.com

  • View Related
  • Share

Most Recently Shared on October 10, 2011 at 4:03 pm By:

nutritionjill Jill Weisenberger Nutritionist and Dietitian

Available in 6 dosages RT @Eatingsoulfully: FDA OKs diabetes, cholesterol combo drug http://t.co/5Wp37M2a #diabetes

7 months ago...

Takeda, AACE partner to launch Diabetes Navigator website

news-medical.net — “The American Association of Clinical Endocrinologists (AACE) and Takeda Pharmaceuticals North America Inc. (Takeda) have partnered to launch the Diabetes Navigator, a compendium capturing a selection of useful and reliable type 2 diabetes information available online for patients and caregivers.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on September 28, 2011 at 11:26 am By:

seniorhomes SeniorHomes.com Health Site

Takeda, AACE partner to launch Diabetes Navigator website http://t.co/ORPZ0V6j

8 months ago...

Advertisement